| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Subunits in the Expression of the Adrenocorticotropin Receptor
Banting and Best Department of Medical Research and Department of Pharmacology University of Toronto Toronto, Ontario, Canada M5G 1L6
Mutant Y1 mouse adrenocortical tumor cells,
isolated on the basis of their resistance to the growth-inhibitory
effects of forskolin, arise from single mutational events. These
mutants present complex phenotypes in which the activity of Gß/
is
impaired, ACTH receptor gene expression is markedly diminished, and
ACTH-responsive adenylyl cyclase activity is lost. In this study, we
have tested the hypothesis that the impairment in Gß/
activity is
responsible for the loss of ACTH receptor gene expression and
ACTH-responsive adenylyl cyclase activity. Transfection of one of the
mutant clones with expression vectors encoding either Gß1 or Gß2
together with G
2 increased ACTH receptor expression and restored
ACTH-responsive adenylyl cyclase activity. Interestingly, either Gß2
or G
2 alone was effective. These results thus support the hypothesis
that the impairment in Gß/
activity is responsible for the loss of
ACTH receptor expression. A luciferase reporter plasmid driven by the
proximal promoter region of the mouse ACTH receptor gene was expressed
poorly in the mutants compared with parental Y1 cells, suggesting that
the Gß/
defect compromised transcriptional activity at the
proximal promoter region of the ACTH receptor gene.
This article has been cited by other articles:
![]() |
S. Roy, M. Rached, and N. Gallo-Payet Differential Regulation of the Human Adrenocorticotropin Receptor [Melanocortin-2 Receptor (MC2R)] by Human MC2R Accessory Protein Isoforms {alpha} and {beta} in Isogenic Human Embryonic Kidney 293 Cells Mol. Endocrinol., July 1, 2007; 21(7): 1656 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frigeri, J. Tsao, W. Czerwinski, and B. P. Schimmer Impaired Steroidogenic Factor 1 (NR5A1) Activity in Mutant Y1 Mouse Adrenocortical Tumor Cells Mol. Endocrinol., April 1, 2000; 14(4): 535 - 544. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |